To evaluate the effect of CD147 in ALK+ ALCL cells, a double approach was pursued using CD147 shRNA KD and CD147 knockout (KO) by CRISPR/Cas9 system (Fig. 3A). The gene discussed is ALK; the disease is anaplastic large cell lymphoma.